Krognes Steve E. (CIK 1666236) reported 24 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-17). Recent activity: Sell GH (1,103 shares), Sell GH (3,300 shares), Sell GH (1,300 shares), Sell GH (971 shares), Buy GH (155 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Guardant Health, Inc. (GH) | Director | Sell | 1,103 | $192,432 |
| 2026-09-17 | Guardant Health, Inc. (GH) | Director | Sell | 3,300 | $578,888 |
| 2026-09-17 | Guardant Health, Inc. (GH) | Director | Sell | 1,300 | $229,236 |
| 2026-09-17 | Guardant Health, Inc. (GH) | Director | Sell | 971 | $172,330 |
| 2026-07-02 | Guardant Health, Inc. (GH) | Director | Buy | 155 | $0 |
| 2026-06-22 | Guardant Health, Inc. (GH) | Director | Buy | 4,203 | $0 |
| 2026-06-05 | Denali Therapeutics Inc. (DNLI) | Director | Buy | 6,408 | $0 |
| 2026-06-05 | Guardant Health, Inc. (GH) | Director | Sell | 9,294 | $1.2M |
| 2026-06-01 | Guardant Health, Inc. (GH) | Director | Buy | 154 | $0 |
| 2026-05-01 | Guardant Health, Inc. (GH) | Director | Buy | 154 | $0 |
| 2026-04-01 | Guardant Health, Inc. (GH) | Director | Buy | 155 | $0 |
| 2026-03-02 | Guardant Health, Inc. (GH) | Director | Buy | 154 | $0 |
| 2026-02-02 | Guardant Health, Inc. (GH) | Director | Buy | 154 | $0 |
| 2026-01-05 | Guardant Health, Inc. (GH) | Director | Buy | 154 | $0 |
| 2025-12-01 | Guardant Health, Inc. (GH) | Director | Buy | 155 | $0 |
| 2025-11-03 | Guardant Health, Inc. (GH) | Director | Buy | 154 | $0 |
| 2025-10-02 | Guardant Health, Inc. (GH) | Director | Buy | 154 | $0 |
| 2025-09-03 | Guardant Health, Inc. (GH) | Director | Buy | 155 | $0 |
| 2025-08-04 | Guardant Health, Inc. (GH) | Director | Buy | 154 | $0 |
| 2025-07-02 | Guardant Health, Inc. (GH) | Director | Buy | 154 | $0 |
| 2025-06-16 | Guardant Health, Inc. (GH) | Director | Buy | 6,674 | $0 |
| 2025-06-05 | Denali Therapeutics Inc. (DNLI) | Director | Buy | 6,037 | $0 |
| 2025-06-02 | Guardant Health, Inc. (GH) | Director | Buy | 154 | $0 |
| 2025-05-01 | Guardant Health, Inc. (GH) | Director | Buy | 155 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-17